This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) rose 1.44% to $2.11 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.09% to 26,293.10 and the Dow Jones Industrial Average rising 0.55% to 50,285.66.
This was the stock's fifth consecutive day of gains.
TherapeuticsMD Inc. closed 28.47% short of its 52-week high of $2.95, which the company achieved on January 27th.
The stock outperformed some of its competitors Thursday, as AbbVie Inc. (ABBV) rose 1.04% to $214.50.
Trading volume (12,896) remained 8,571 below its 50-day average volume of 21,467.
Data source: Dow Jones Market Data, FactSet. Data compiled May 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-21-26 1733ET

TXMD

TherapeuticsMD Inc. (TXMD) shares rose 1.44% to $2.11 on a positive trading day, marking the fifth consecutive day of gains. The stock remains 28.47% below its 52-week high of $2.95. In comparison, AbbVie Inc. (ABBV) increased by 1.04% to $214.50. Trading volume was below the 50-day average.

MarketWatch Automated

Therapeutics MD

SPDR S&P Biotech

iShares Biotechnology ETF

iShares US Pharma

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

Health Care Select Sector SPDR

VG Health

Direxion S&P Biotech Bear 3X

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

Direxion S&P Biotech Bull 3X

ALPS Medical Breakthrough

NASDAQ Composite Index

Dow Jones Industrial Average

Abbvie

Factset Research

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day